IAIM
MTNB icon

International Assets Investment Management’s Matinas BioPharma MTNB Stock Holding History

International Assets Investment Management’s Portfolio MTNB Stock Details MTNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-41
Closed -$3K – 1364
2021
Q1 		$3K Hold
41
– – ﹤0.01% 1946
2020
Q4 		$3K Buy
+41
New +$1.9K ﹤0.01% 1801

Other funds holding MTNB

BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
CCM
Courage Capital Management Nashville, Tennessee $70.6M AUM 13.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

International Assets Investment Management's MTNB Position: Q2 2021 in Review

International Assets Investment Management sold out of Matinas BioPharma (MTNB) in Q2 2021, closing a stake of 41 shares — an estimated $3K sold.

International Assets Investment Management first reported a position in MTNB in Q4 2020 and held it in 2 quarters. The position peaked at $3K in Q1 2021. 67 funds tracked by Wall St. Rank hold MTNB as of Q2 2021.

  • International Assets Investment Management reported no remaining Matinas BioPharma position as of Q2 2021 after selling out during the quarter.
  • International Assets Investment Management sold 41 Matinas BioPharma shares in Q2 2021, an estimated $3K.
  • International Assets Investment Management first reported a position in Matinas BioPharma in Q4 2020 and held it in 2 quarters.
  • International Assets Investment Management's Matinas BioPharma position peaked at $3K in Q1 2021.
  • 67 funds tracked by Wall St. Rank held Matinas BioPharma as of Q2 2021.

Based on International Assets Investment Management's 13F filing for Q2 2021, filed 14 Jul 2021.